Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Jun 24, 2026
Berkshire Hathaway Builds a Position in Macy's (M): Key Developments to Watch

Berkshire Hathaway Builds a Position in Macy's (M): Key Developments to Watch

Key Takeaways

  • Berkshire Hathaway disclosed a new position in Macy's during its latest 13F filing, marking its first department store investment in decades.
  • The company is scheduled to report first-quarter results on June 3, 2026, with analysts expecting sharply lower earnings per share.
  • Shareholders recently approved an updated equity incentive plan at the annual meeting.
  • Analyst consensus remains cautious, with several firms maintaining Hold ratings ahead of earnings.
  • A quarterly dividend of $0.19 per share was declared, supporting a yield above 3%.

Market Context for Macy's Shares

In recent weeks, Macy's shares have experienced notable volatility driven by a mix of corporate developments and broader retail sector sentiment. Investor attention has centered on major institutional moves and the upcoming earnings release, with the stock reflecting both optimism from new ownership signals and caution over near-term profitability pressures. Trading activity has remained elevated as market participants assess the company's strategic positioning ahead of the next reporting cycle. From what I see, this setup creates an interesting environment for monitoring institutional interest alongside operational updates.

Recent Developments Shaping the Stock

Berkshire Hathaway’s 13F filing, released in mid-May 2026, revealed a new stake in Macy's valued at approximately $55 million. This disclosure represented the investment firm's first meaningful position in a department store retailer since the 1960s and triggered an immediate positive market reaction, with shares rising several percentage points in after-hours trading. The move was interpreted by investors as a vote of confidence in Macy's real estate holdings, Bloomingdale's brand strength, and overall valuation. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Shortly thereafter, Macy's held its annual shareholder meeting on May 18, 2026, where participants approved an updated equity incentive plan. The approval cleared the way for continued alignment between management compensation and long-term performance goals. Around the same period, the company declared its fourth-quarter dividend of $0.19 per share, payable in early July, maintaining a payout ratio viewed as sustainable by many observers.

Analyst activity in late May included a Hold rating affirmation from Telsey Advisory Group, reflecting balanced views on near-term execution amid ongoing store optimization efforts. Broader market commentary highlighted persistent challenges in the department store segment, including competitive pressures from e-commerce and changing consumer spending patterns. These factors contributed to tempered sentiment even as the Berkshire news provided a counterbalance.

Looking ahead to the June 3 earnings release, consensus estimates point to revenue of roughly $4.62 billion, representing modest year-over-year growth, while earnings per share are projected to decline sharply to $0.02. This anticipated compression has kept investor focus squarely on operational updates and any forward guidance adjustments that may accompany the results.

2026 Outlook and Factors Worth Monitoring

As Macy's progresses through 2026, investors will likely track the company's progress on its multi-year restructuring initiatives, including store rationalization and digital channel expansion. Management's ability to stabilize comparable sales and manage inventory levels amid evolving consumer preferences will remain central to performance. Macroeconomic conditions, particularly discretionary spending trends and interest rate trajectories, could influence both top-line results and margin outcomes. I'm watching this closely as these elements often determine whether the recent institutional signal translates into sustained momentum.

Additional areas of focus include the execution of brand partnerships, such as recent designer collaborations, and the competitive positioning of Bloomingdale's relative to peers. Regulatory or tax considerations affecting retail real estate portfolios may also warrant attention. Finally, any shifts in institutional ownership patterns, building on the recent Berkshire disclosure, could serve as sentiment indicators throughout the year.

Using AI Tools to Support Stock Research

In my view, combining traditional analysis with modern tools can provide additional perspective on names like Macy's. Tickeron’s Trending AI Robots page showcases a curated selection of high-performing AI trading bots from its extensive library. While Tickeron offers hundreds of AI Trading Bots capable of trading thousands of different tickers, only those demonstrating the strongest alignment with prevailing market conditions earn placement in this focused section. Available bots span a wide range of trading styles, strategies, timeframes, and performance statistics, allowing users to identify options suited to various risk profiles and objectives. I have found this page useful for exploring how different automated approaches align with current market conditions before earnings events. Explore the full selection on the Trending AI Robots page for detailed metrics and live performance data.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: M

Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


M in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 09, 2026

M may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 29 of 35 cases where M's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where M's RSI Oscillator exited the oversold zone, 16 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.

The Momentum Indicator moved above the 0 level on September 22, 2026. You may want to consider a long position or call options on M as a result. In 66 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.

The Moving Average Convergence Divergence (MACD) for M just turned positive on September 15, 2026. Looking at past instances where M's MACD turned positive, the stock continued to rise in 36 of 50 cases over the following month. The odds of a continued upward trend are 72%.

Following a +2.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where M advanced for three days, in 208 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 51 of 65 cases where M's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 78%.

M moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where M declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

The Aroon Indicator for M entered a downward trend on September 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. M’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 53 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.220) is normal, around the industry mean (2.246). P/E Ratio (8.429) is within average values for comparable stocks, (10.619). Projected Growth (PEG Ratio) (2.624) is also within normal values, averaging (1.329). Dividend Yield (0.033) settles around the average of (0.020) among similar stocks. P/S Ratio (0.262) is also within normal values, averaging (19.276).

The Tickeron Profit vs. Risk Rating rating for this company is 84 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. M’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

Notable companies

The most notable companies in this group are Macy's (NYSE:M), Kohls Corp (NYSE:KSS).

Industry description

A department store sells a wide variety of consumer goods under different “departments,” including (but not necessarily limited to) apparel, household appliances, home furnishings, personal care products, cosmetics, consumer electronics. During healthy macroeconomic conditions, consumers typically won’t shy away from big-ticket purchases; but during a downturn, consumer spending might get limited to the most necessary/daily essentials. Several department stores purchase items on bulk from manufacturers for resale to consumers at a profit. Some of the largest department stores companies in the U.S. include Kohl’s Corporation, Macy’s Inc., and Ollie’s Bargain Outlet Holdings Inc.

Market Cap

The average market capitalization across the Department Stores Industry is 5.19B. The market cap for tickers in the group ranges from 208.1K to 7.88T. MHRTF holds the highest valuation in this group at 7.88T. The lowest valued company is BONT at 208.1K.

High and low price notable news

The average weekly price growth across all stocks in the Department Stores Industry was 2%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 11%. KSS experienced the highest price growth at 7%, while M experienced the biggest fall at -2%.

Volume

The average weekly volume growth across all stocks in the Department Stores Industry was 3%. For the same stocks of the Industry, the average monthly volume growth was 72% and the average quarterly volume growth was 3%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 70
Price Growth Rating: 47
SMR Rating: 72
Profit Risk Rating: 79
Seasonality Score: 55 (-100 ... +100)
View a ticker or compare two or three
M
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an operator of department stores

Industry DepartmentStores

Industry
Department Stores
Address
151 West 34th Street
Phone
+1 212 494-1621
Employees
90134
Web
https://www.macysinc.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.